The Journal of clinical psychiatry
-
Randomized Controlled Trial Multicenter Study Clinical Trial
A randomized placebo-controlled trial of risperidone for the treatment of aggression, agitation, and psychosis of dementia.
This randomized, double-blind, placebo-controlled trial examined the efficacy and safety of risperidone in the treatment of aggression, agitation, and psychosis in elderly nursing-home patients with dementia. ⋯ Treatment with low-dose (mean = 0.95 mg/day) risperidone resulted in significant improvement in aggression, agitation, and psychosis associated with dementia.